Overview
This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 114 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.
Eligibility
Inclusion Criteria:
- Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.
- Adult patient able to give his written consent
- Patient affiliated to the French Social Security system
Exclusion Criteria:
- Vulnerable patients
- Patients with liver ascites
- Patients with heart failure